{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:18:57Z","timestamp":1760908737674},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,1,12]],"date-time":"2012-01-12T00:00:00Z","timestamp":1326326400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s10147-011-0368-2","type":"journal-article","created":{"date-parts":[[2012,1,11]],"date-time":"2012-01-11T05:08:24Z","timestamp":1326258504000},"page":"33-39","source":"Crossref","is-referenced-by-count":13,"title":["Practical approaches to diagnose and treat for T0 malignant pleural mesothelioma: a proposal for diagnostic total parietal pleurectomy"],"prefix":"10.1007","volume":"17","author":[{"given":"Seiki","family":"Hasegawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruhisa","family":"Takuwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayato","family":"Orui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunichi","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazue","family":"Yoneda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitomo","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriaki","family":"Tsubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Fukuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuko","family":"Torii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Tsujimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,1,12]]},"reference":[{"issue":"2","key":"368_CR1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0169-5002(01)00257-4","volume":"34","author":"GL Ceresoli","year":"2001","unstructured":"Ceresoli GL, Locati LD, Ferreri AJ et al (2001) Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma. Lung cancer 34(2):279\u2013287","journal-title":"Lung cancer"},{"issue":"15","key":"368_CR2","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","volume":"353","author":"BW Robinson","year":"2005","unstructured":"Robinson BW, Lake RA (2005) Advances in malignant mesothelioma. N Engl J Med 353(15):1591\u20131603. doi: 10.1056\/NEJMra050152","journal-title":"N Engl J Med"},{"issue":"3","key":"368_CR3","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ncponc1039","volume":"5","author":"DA Fennell","year":"2008","unstructured":"Fennell DA, Gaudino G, O\u2019Byrne KJ et al (2008) Advances in the systemic therapy of malignant pleural mesothelioma. Nat Clin Pract Oncol 5(3):136\u2013147. doi: 10.1038\/ncponc1039","journal-title":"Nat Clin Pract Oncol"},{"issue":"7","key":"368_CR4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11748-007-0243-2","volume":"56","author":"S Hasegawa","year":"2008","unstructured":"Hasegawa S, Tanaka F (2008) Malignant mesothelioma: current status and perspective in Japan and the world. Gen Thorac Cardiovasc Surg 56(7):317\u2013323. doi: 10.1007\/s11748-007-0243-2","journal-title":"Gen Thorac Cardiovasc Surg"},{"issue":"2","key":"368_CR5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/j.semtcvs.2009.06.007","volume":"21","author":"HI Pass","year":"2009","unstructured":"Pass HI, Carbone M (2009) Current status of screening for malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg 21(2):97\u2013104. doi: 10.1053\/j.semtcvs.2009.06.007","journal-title":"Semin Thorac Cardiovasc Surg"},{"issue":"12","key":"368_CR6","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1200\/JCO.2008.19.8523","volume":"27","author":"AS Tsao","year":"2009","unstructured":"Tsao AS, Wistuba I, Roth JA et al (2009) Malignant pleural mesothelioma. J Clin Oncol 27(12):2081\u20132090. doi: 10.1200\/JCO.2008.19.8523","journal-title":"J Clin Oncol"},{"issue":"11","key":"368_CR7","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1097\/JTO.0b013e3181f1cf2b","volume":"5","author":"MT Milano","year":"2010","unstructured":"Milano MT, Zhang H (2010) Malignant pleural mesothelioma: a population-based study of survival. J Thorac Oncol 5(11):1841\u20131848. doi: 10.1097\/JTO.0b013e3181f1cf2b","journal-title":"J Thorac Oncol"},{"issue":"9","key":"368_CR8","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1158\/1055-9965.EPI-10-0346","volume":"19","author":"J Creaney","year":"2010","unstructured":"Creaney J, Olsen NJ, Brims F et al (2010) Serum mesothelin for early detection of asbestos-induced cancer malignant mesothelioma. Cancer Epidemiol Biomarkers Prev 19(9):2238\u20132246. doi: 10.1158\/1055-9965.EPI-10-0346","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"368_CR9","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5223(99)70469-1","volume":"117","author":"DJ Sugarbaker","year":"1999","unstructured":"Sugarbaker DJ, Flores RM, Jaklitsch MT et al (1999) Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 117(1):54\u201363 (discussion 63\u201365)","journal-title":"J Thorac Cardiovasc Surg"},{"key":"368_CR10","doi-asserted-by":"crossref","unstructured":"Flores RM, Pass HI, Seshan VE et al (2008) Extrapleural pneumonectomy versus pleurectomy\/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg 135 (3):620\u2013626, 626. e1\u2013626. e3. doi: 10.1016\/j.jtcvs.2007.10.054","DOI":"10.1016\/j.jtcvs.2007.10.054"},{"issue":"9","key":"368_CR11","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1200\/JCO.2008.17.5604","volume":"27","author":"M Perrot de","year":"2009","unstructured":"de Perrot M, Feld R, Cho BC et al (2009) Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Clin Oncol 27(9):1413\u20131418. doi: 10.1200\/JCO.2008.17.5604","journal-title":"J Clin Oncol"},{"issue":"2","key":"368_CR12","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/1097-0142(19930715)72:2<394::AID-CNCR2820720214>3.0.CO;2-5","volume":"72","author":"C Boutin","year":"1993","unstructured":"Boutin C, Rey F, Gouvernet J et al (1993) Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 2: prognosis and staging. Cancer 72(2):394\u2013404","journal-title":"Cancer"},{"issue":"7","key":"368_CR13","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/jcp.52.7.535","volume":"52","author":"J Scurry","year":"1999","unstructured":"Scurry J, Duggan MA (1999) Malignant mesothelioma eight years after a diagnosis of atypical mesothelial hyperplasia. J Clin Pathol 52(7):535\u2013537","journal-title":"J Clin Pathol"},{"issue":"3","key":"368_CR14","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1183\/09031936.00063109","volume":"35","author":"A Scherpereel","year":"2010","unstructured":"Scherpereel A, Astoul P, Baas P et al (2010) Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Eur Respir J 35(3):479\u2013495. doi: 10.1183\/09031936.00063109","journal-title":"Eur Respir J"},{"issue":"7","key":"368_CR15","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1440-1843.2011.02020.x","volume":"16","author":"JP Meerbeeck van","year":"2011","unstructured":"van Meerbeeck JP, Damhuis R (2011) Facts, rumours and speculations about the mesothelioma epidemic. Respirology 16(7):1018\u20131019. doi: 10.1111\/j.1440-1843.2011.02020.x","journal-title":"Respirology"},{"issue":"2","key":"368_CR16","first-page":"151","volume":"9","author":"D Whitaker","year":"1992","unstructured":"Whitaker D, Henderson DW, Shilkin KB (1992) The concept of mesothelioma in situ: implications for diagnosis and histogenesis. Semin Diagn Pathol 9(2):151\u2013161","journal-title":"Semin Diagn Pathol"},{"issue":"3","key":"368_CR17","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/ajcp\/110.3.397","volume":"110","author":"DW Henderson","year":"1998","unstructured":"Henderson DW, Shilkin KB, Whitaker D (1998) Reactive mesothelial hyperplasia vs mesothelioma, including mesothelioma in situ: a brief review. Am J Clin Pathol 110(3):397\u2013404","journal-title":"Am J Clin Pathol"},{"issue":"9","key":"368_CR18","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1097\/00000478-200009000-00001","volume":"24","author":"A Churg","year":"2000","unstructured":"Churg A, Colby TV, Cagle P et al (2000) The separation of benign and malignant mesothelial proliferations. Am J Surg Pathol 24(9):1183\u20131200","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"368_CR19","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.5858\/2005-129-1421-DDOBAM","volume":"129","author":"PT Cagle","year":"2005","unstructured":"Cagle PT, Churg A (2005) Differential diagnosis of benign and malignant mesothelial proliferations on pleural biopsies. Arch Pathol Lab Med 129(11):1421\u20131427. doi: 10.1043\/1543-2165(2005)1292.0.CO;2","journal-title":"Arch Pathol Lab Med"},{"issue":"8","key":"368_CR20","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.5858\/133.8.1317","volume":"133","author":"AN Husain","year":"2009","unstructured":"Husain AN, Colby TV, Ordonez NG et al (2009) Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med 133(8):1317\u20131331. doi: 10.1043\/1543-2165-133.8.1317","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"368_CR21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2559.2008.03178.x","volume":"54","author":"B Addis","year":"2009","unstructured":"Addis B, Roche H (2009) Problems in mesothelioma diagnosis. Histopathology 54(1):55\u201368. doi: 10.1111\/j.1365-2559.2008.03178.x","journal-title":"Histopathology"},{"issue":"10","key":"368_CR22","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1097\/JTO.0b013e3181ed0489","volume":"5","author":"CQ Cao","year":"2010","unstructured":"Cao CQ, Yan TD, Bannon PG et al (2010) A systematic review of extrapleural pneumonectomy for malignant pleural mesothelioma. J Thorac Oncol 5(10):1692\u20131703. doi: 10.1097\/JTO.0b013e3181ed0489","journal-title":"J Thorac Oncol"},{"issue":"8","key":"368_CR23","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1164\/rccm.200806-955ED","volume":"178","author":"JP Meerbeeck van","year":"2008","unstructured":"van Meerbeeck JP, Hillerdal G (2008) Screening for mesothelioma: more harm than good? Am J Respir Crit Care Med 178(8):781\u2013782. doi: 10.1164\/rccm.200806-955ED","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"368_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2010.05.016","volume":"70","author":"AK Nowak","year":"2010","unstructured":"Nowak AK, Armato SG 3rd, Ceresoli GL et al (2010) Imaging in pleural mesothelioma: a review of imaging research presented at the 9th International Meeting of the International Mesothelioma Interest Group. Lung cancer 70(1):1\u20136. doi: 10.1016\/j.lungcan.2010.05.016","journal-title":"Lung cancer"},{"key":"368_CR25","doi-asserted-by":"crossref","unstructured":"Hooper C, Lee YC, Maskell N (2010) Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax 65(Suppl 2):ii4\u2013ii17. doi: 10.1136\/thx.2010.136978","DOI":"10.1136\/thx.2010.136978"},{"issue":"3","key":"368_CR26","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1440-1843.2011.01957.x","volume":"16","author":"PT Cagle","year":"2011","unstructured":"Cagle PT, Allen TC (2011) Pathology of the pleura: what the pulmonologists need to know. Respirology 16(3):430\u2013438. doi: 10.1111\/j.1440-1843.2011.01957.x","journal-title":"Respirology"},{"issue":"1","key":"368_CR27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0169-5002(01)00294-X","volume":"35","author":"M Tiitola","year":"2002","unstructured":"Tiitola M, Kivisaari L, Huuskonen MS et al (2002) Computed tomography screening for lung cancer in asbestos-exposed workers. Lung cancer 35(1):17\u201322","journal-title":"Lung cancer"},{"issue":"1","key":"368_CR28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00420-009-0462-1","volume":"83","author":"T Vierikko","year":"2010","unstructured":"Vierikko T, Jarvenpaa R, Toivio P et al (2010) Clinical and HRCT screening of heavily asbestos-exposed workers. Int Arch Occup Environ Health 83(1):47\u201354. doi: 10.1007\/s00420-009-0462-1","journal-title":"Int Arch Occup Environ Health"},{"issue":"10","key":"368_CR29","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1634\/theoncologist.12-10-1215","volume":"12","author":"G Fasola","year":"2007","unstructured":"Fasola G, Belvedere O, Aita M et al (2007) Low-dose computed tomography screening for lung cancer and pleural mesothelioma in an asbestos-exposed population: baseline results of a prospective, nonrandomized feasibility trial\u2014an Alpe-adria Thoracic Oncology Multidisciplinary Group Study (ATOM 002). Oncologist 12(10):1215\u20131224. doi: 10.1634\/theoncologist.12-10-1215","journal-title":"Oncologist"},{"issue":"5","key":"368_CR30","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/JTO.0b013e31819f2e0e","volume":"4","author":"HC Roberts","year":"2009","unstructured":"Roberts HC, Patsios DA, Paul NS et al (2009) Screening for malignant pleural mesothelioma and lung cancer in individuals with a history of asbestos exposure. J Thorac Oncol 4(5):620\u2013628. doi: 10.1097\/JTO.0b013e31819f2e0e","journal-title":"J Thorac Oncol"},{"issue":"6","key":"368_CR31","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3109\/15563650.2010.506876","volume":"48","author":"M Lotti","year":"2010","unstructured":"Lotti M, Bergamo L, Murer B (2010) Occupational toxicology of asbestos-related malignancies. Clin Toxicol (Phila) 48(6):485\u2013496. doi: 10.3109\/15563650.2010.506876","journal-title":"Clin Toxicol (Phila)"},{"issue":"12","key":"368_CR32","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/dc.21303","volume":"38","author":"EA Rakha","year":"2010","unstructured":"Rakha EA, Patil S, Abdulla K et al (2010) The sensitivity of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma. Diagn Cytopathol 38(12):874\u2013879. doi: 10.1002\/dc.21303","journal-title":"Diagn Cytopathol"},{"issue":"11","key":"368_CR33","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/JTO.0b013e318189f53d","volume":"3","author":"S Bielsa","year":"2008","unstructured":"Bielsa S, Martin-Juan J, Porcel JM et al (2008) Diagnostic and prognostic implications of pleural adhesions in malignant effusions. J Thorac Oncol 3(11):1251\u20131256. doi: 10.1097\/JTO.0b013e318189f53d","journal-title":"J Thorac Oncol"},{"issue":"3","key":"368_CR34","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1378\/chest.08-2665","volume":"136","author":"M Ray","year":"2009","unstructured":"Ray M, Kindler HL (2009) Malignant pleural mesothelioma: an update on biomarkers and treatment. Chest 136(3):888\u2013896. doi: 10.1378\/chest.08-2665","journal-title":"Chest"},{"issue":"2","key":"368_CR35","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1510\/icvts.2010.255893","volume":"12","author":"I Zahid","year":"2011","unstructured":"Zahid I, Sharif S, Routledge T et al (2011) What is the best way to diagnose and stage malignant pleural mesothelioma? Interact Cardiovasc Thorac Surg 12(2):254\u2013259. doi: 10.1510\/icvts.2010.255893","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"8","key":"368_CR36","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1038\/bjc.2011.104","volume":"104","author":"S Bij van der","year":"2011","unstructured":"van der Bij S, Schaake E, Koffijberg H et al (2011) Markers for the non-invasive diagnosis of mesothelioma: a systematic review. Br J Cancer 104(8):1325\u20131333. doi: 10.1038\/bjc.2011.104","journal-title":"Br J Cancer"},{"issue":"4","key":"368_CR37","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ejcts.2010.01.057","volume":"38","author":"HE Davies","year":"2010","unstructured":"Davies HE, Nicholson JE, Rahman NM et al (2010) Outcome of patients with nonspecific pleuritis\/fibrosis on thoracoscopic pleural biopsies. Eur J Cardiothorac Surg 38(4):472\u2013477. doi: 10.1016\/j.ejcts.2010.01.057","journal-title":"Eur J Cardiothorac Surg"},{"key":"368_CR38","doi-asserted-by":"crossref","unstructured":"Cao C, Andvik SK, Yan TD et al (2011) Staging of patients after extrapleural pneumonectomy for malignant pleural mesothelioma\u2014institutional review and current update. Interact Cardiovasc Thorac Surg. doi: 10.1510\/icvts.2010.262972","DOI":"10.1510\/icvts.2010.262972"},{"issue":"9396","key":"368_CR39","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/S0140-6736(03)14794-0","volume":"362","author":"B Robinson","year":"2003","unstructured":"Robinson B, Creaney J, Lake R et al (2003) Mesothelin-family proteins and diagnosis of mesothelioma. Lancet 362(9396):1612\u20131616. doi: 10.1016\/s0140-6736(03)14794-0","journal-title":"Lancet"},{"issue":"8","key":"368_CR40","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1164\/rccm.200802-258OC","volume":"178","author":"EK Park","year":"2008","unstructured":"Park EK, Sandrini A, Yates DH et al (2008) Soluble mesothelin-related protein in an asbestos-exposed population: the dust diseases board cohort study. Am J Respir Crit Care Med 178(8):832\u2013837. doi: 10.1164\/rccm.200802-258OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"368_CR41","doi-asserted-by":"crossref","first-page":"158","DOI":"10.5694\/j.1326-5377.2009.tb02321.x","volume":"190","author":"EL O\u2019Lone","year":"2009","unstructured":"O\u2019Lone EL, Park EK, Sandrini A et al (2009) Early detection of malignant pleural mesothelioma through measurement of soluble mesothelin-related protein and positron emission tomography. Med J Aust 190(3):158\u2013159","journal-title":"Med J Aust"},{"issue":"7","key":"368_CR42","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/thx.2006.068114","volume":"62","author":"J Creaney","year":"2007","unstructured":"Creaney J, Yeoman D, Naumoff LK et al (2007) Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma. Thorax 62(7):569\u2013576. doi: 10.1136\/thx.2006.068114","journal-title":"Thorax"},{"issue":"1","key":"368_CR43","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.athoracsur.2007.07.042","volume":"85","author":"HI Pass","year":"2008","unstructured":"Pass HI, Wali A, Tang N et al (2008) Soluble mesothelin-related peptide level elevation in mesothelioma serum and pleural effusions. Ann Thorac Surg 85(1):265\u2013272. doi: 10.1016\/j.athoracsur.2007.07.042 discussion 272","journal-title":"Ann Thorac Surg"},{"issue":"10","key":"368_CR44","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1515\/CCLM.2011.242","volume":"49","author":"S Yamada","year":"2011","unstructured":"Yamada S, Tabata C, Tabata R et al (2011) Clinical significance of pleural effusion mesothelin in malignant pleural mesothelioma. Clin Chem Lab Med 49(10):1721\u20131726. doi: 10.1515\/CCLM.2011.242","journal-title":"Clin Chem Lab Med"},{"issue":"7","key":"368_CR45","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/thx.2006.076612","volume":"62","author":"YC Lee","year":"2007","unstructured":"Lee YC (2007) Hunting for a pleural fluid test for mesothelioma: is soluble mesothelin the answer? Thorax 62(7):561\u2013562. doi: 10.1136\/thx.2006.076612","journal-title":"Thorax"},{"issue":"5","key":"368_CR46","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1164\/rccm.200811-1729OC","volume":"180","author":"HE Davies","year":"2009","unstructured":"Davies HE, Sadler RS, Bielsa S et al (2009) Clinical impact and reliability of pleural fluid mesothelin in undiagnosed pleural effusions. Am J Respir Crit Care Med 180(5):437\u2013444. doi: 10.1164\/rccm.200811-1729OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"368_CR47","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2559.2005.02331.x","volume":"48","author":"JE King","year":"2006","unstructured":"King JE, Thatcher N, Pickering CA et al (2006) Sensitivity and specificity of immunohistochemical markers used in the diagnosis of epithelioid mesothelioma: a detailed systematic analysis using published data. Histopathology 48(3):223\u2013232. doi: 10.1111\/j.1365-2559.2005.02331.x","journal-title":"Histopathology"},{"issue":"11","key":"368_CR48","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/modpathol.2010.134","volume":"23","author":"A Sato","year":"2010","unstructured":"Sato A, Torii I, Okamura Y et al (2010) Immunocytochemistry of CD146 is useful to discriminate between malignant pleural mesothelioma and reactive mesothelium. Mod Pathol 23(11):1458\u20131466. doi: 10.1038\/modpathol.2010.134","journal-title":"Mod Pathol"},{"issue":"1","key":"368_CR49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1349-7006.2009.01336.x","volume":"101","author":"Y Sekido","year":"2010","unstructured":"Sekido Y (2010) Genomic abnormalities and signal transduction dysregulation in malignant mesothelioma cells. Cancer Sci 101(1):1\u20136. doi: 10.1111\/j.1349-7006.2009.01336.x","journal-title":"Cancer Sci"},{"issue":"1","key":"368_CR50","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1440-1843.2010.01890.x","volume":"16","author":"GT Stathopoulos","year":"2011","unstructured":"Stathopoulos GT (2011) Translational advances in pleural malignancies. Respirology 16(1):53\u201363. doi: 10.1111\/j.1440-1843.2010.01890.x","journal-title":"Respirology"},{"key":"368_CR51","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-3-642-10862-4_10","volume":"189","author":"S Klebe","year":"2011","unstructured":"Klebe S, Henderson DW (2011) Early stages of mesothelioma, screening and biomarkers. Recent Results Cancer Res 189:169\u2013193. doi: 10.1007\/978-3-642-10862-4_10","journal-title":"Recent Results Cancer Res"},{"issue":"1","key":"368_CR52","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/cncr.10923","volume":"99","author":"PB Illei","year":"2003","unstructured":"Illei PB, Ladanyi M, Rusch VW et al (2003) The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions. Cancer 99(1):51\u201356. doi: 10.1002\/cncr.10923","journal-title":"Cancer"},{"issue":"21","key":"368_CR53","first-page":"5547","volume":"54","author":"JQ Cheng","year":"1994","unstructured":"Cheng JQ, Jhanwar SC, Klein WM et al (1994) p16 alterations and deletion mapping of 9p21\u2013p22 in malignant mesothelioma. Cancer Res 54(21):5547\u20135551","journal-title":"Cancer Res"},{"issue":"3","key":"368_CR54","first-page":"511","volume":"11","author":"S Xio","year":"1995","unstructured":"Xio S, Li D, Vijg J et al (1995) Codeletion of p15 and p16 in primary malignant mesothelioma. Oncogene 11(3):511\u2013515","journal-title":"Oncogene"},{"issue":"24","key":"368_CR55","doi-asserted-by":"crossref","first-page":"10854","DOI":"10.1073\/pnas.92.24.10854","volume":"92","author":"AB Bianchi","year":"1995","unstructured":"Bianchi AB, Mitsunaga SI, Cheng JQ et al (1995) High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas. Proc Natl Acad Sci USA 92(24):10854\u201310858","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"368_CR56","first-page":"1227","volume":"55","author":"Y Sekido","year":"1995","unstructured":"Sekido Y, Pass HI, Bader S et al (1995) Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer. Cancer Res 55(6):1227\u20131231","journal-title":"Cancer Res"},{"issue":"2","key":"368_CR57","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.lungcan.2008.08.014","volume":"64","author":"C Thurneysen","year":"2009","unstructured":"Thurneysen C, Opitz I, Kurtz S et al (2009) Functional inactivation of NF2\/merlin in human mesothelioma. Lung cancer 64(2):140\u2013147. doi: 10.1016\/j.lungcan.2008.08.014","journal-title":"Lung cancer"},{"issue":"7","key":"368_CR58","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ng.855","volume":"43","author":"M Bott","year":"2011","unstructured":"Bott M, Brevet M, Taylor BS et al (2011) The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma. Nat Genet 43(7):668\u2013672. doi: 10.1038\/ng.855","journal-title":"Nat Genet"},{"issue":"10","key":"368_CR59","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","volume":"43","author":"JR Testa","year":"2011","unstructured":"Testa JR, Cheung M, Pei J et al (2011) Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet 43(10):1022\u20131025. doi: 10.1038\/ng.912","journal-title":"Nat Genet"},{"issue":"6","key":"368_CR60","first-page":"1365","volume":"39","author":"Y Yoshikawa","year":"2011","unstructured":"Yoshikawa Y, Sato A, Tsujimura T et al (2011) Frequent deletion of 3p21.1 region carrying semaphorin 3G and aberrant expression of the genes participating in semaphorin signaling in the epithelioid type of malignant mesothelioma cells. Int J Oncol 39(6):1365\u20131374. doi: 10.3892\/ijo.2011.1158","journal-title":"Int J Oncol"},{"issue":"6","key":"368_CR61","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.athoracsur.2009.03.073","volume":"87","author":"Y Okumura","year":"2009","unstructured":"Okumura Y, Tanaka F, Yoneda K et al (2009) Circulating tumor cells in pulmonary venous blood of primary lung cancer patients. Ann Thorac Surg 87(6):1669\u20131675. doi: 10.1016\/j.athoracsur.2009.03.073","journal-title":"Ann Thorac Surg"},{"issue":"22","key":"368_CR62","doi-asserted-by":"crossref","first-page":"6980","DOI":"10.1158\/1078-0432.CCR-09-1095","volume":"15","author":"F Tanaka","year":"2009","unstructured":"Tanaka F, Yoneda K, Kondo N et al (2009) Circulating tumor cell as a diagnostic marker in primary lung cancer. Clin Cancer Res 15(22):6980\u20136986. doi: 10.1158\/1078-0432.CCR-09-1095","journal-title":"Clin Cancer Res"},{"key":"368_CR63","doi-asserted-by":"crossref","unstructured":"Tanaka F (2011) Circulating tumor cell (CTC) as a clinical marker in malignant pleural mesothelioma (MPM). J Clin Oncol 29(suppl):abstr 10572","DOI":"10.1200\/jco.2011.29.15_suppl.10572"},{"key":"368_CR64","doi-asserted-by":"crossref","unstructured":"Yoneda K (2011) Circulating endothelial cell (CEC), a surrogate of tumor angiogenesis, as a diagnostic and prognostic marker in malignant pleural mesothelioma (MPM). J Clin Oncol 29(suppl):abstr 10577","DOI":"10.1200\/jco.2011.29.15_suppl.10577"},{"issue":"2","key":"368_CR65","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/1097-0142(19930715)72:2<389::AID-CNCR2820720213>3.0.CO;2-V","volume":"72","author":"C Boutin","year":"1993","unstructured":"Boutin C, Rey F (1993) Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 1: diagnosis. Cancer 72(2):389\u2013393","journal-title":"Cancer"},{"key":"368_CR66","doi-asserted-by":"crossref","unstructured":"Committee BTSSoC (2007) BTS statement on malignant mesothelioma in the UK, 2007. Thorax 62(Suppl 2):ii1\u2013ii19. doi: 10.1136\/thx.2007.087619","DOI":"10.1136\/thx.2007.087619"},{"issue":"1","key":"368_CR67","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0003-4975(89)90179-3","volume":"48","author":"RD Page","year":"1989","unstructured":"Page RD, Jeffrey RR, Donnelly RJ (1989) Thoracoscopy: a review of 121 consecutive surgical procedures. Ann Thorac Surg 48(1):66\u201368","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"368_CR68","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1378\/chest.107.3.845","volume":"107","author":"RJ Harris","year":"1995","unstructured":"Harris RJ, Kavuru MS, Mehta AC et al (1995) The impact of thoracoscopy on the management of pleural disease. Chest 107(3):845\u2013852","journal-title":"Chest"},{"issue":"3","key":"368_CR69","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1378\/chest.127.3.1017","volume":"127","author":"J Ferrer","year":"2005","unstructured":"Ferrer J, Roldan J, Teixidor J et al (2005) Predictors of pleural malignancy in patients with pleural effusion undergoing thoracoscopy. Chest 127(3):1017\u20131022. doi: 10.1378\/chest.127.3.1017","journal-title":"Chest"},{"issue":"4","key":"368_CR70","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ijsu.2008.04.004","volume":"6","author":"S Neragi-Miandoab","year":"2008","unstructured":"Neragi-Miandoab S, Richards WG, Sugarbaker DJ (2008) Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma. Int J Surg 6(4):293\u2013297. doi: 10.1016\/j.ijsu.2008.04.004","journal-title":"Int J Surg"},{"issue":"2","key":"368_CR71","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/01243894-200602000-00014","volume":"1","author":"DJ Sugarbaker","year":"2006","unstructured":"Sugarbaker DJ (2006) Macroscopic complete resection: the goal of primary surgery in multimodality therapy for pleural mesothelioma. J Thorac Oncol 1(2):175\u2013176","journal-title":"J Thorac Oncol"},{"key":"368_CR72","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1097\/JTO.0b013e3182208e3f","volume":"6","author":"D Rice","year":"2011","unstructured":"Rice D, Rusch VW, Pass H et al (2011) Recommendations for Uniform Definitions of Surgical Techniques for Malignant Pleural Mesothelioma. A Consensus Report of the International Association for the Study of Lung Cancer International Staging Committee and the International Mesothelioma Interest Group. J Thorac Oncol 6:1304\u20131312","journal-title":"J Thorac Oncol"},{"key":"368_CR73","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/S0169-5002(07)70424-5","volume":"57","author":"P Baas","year":"2007","unstructured":"Baas P (2007) Optimising survival in malignant mesothelioma. Lung Cancer 57:S24\u2013S29. doi: 10.1016\/s0169-5002(07)70424-5","journal-title":"Lung Cancer"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-011-0368-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-011-0368-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-011-0368-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,25]],"date-time":"2021-12-25T18:55:45Z","timestamp":1640458545000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-011-0368-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,12]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["368"],"URL":"https:\/\/doi.org\/10.1007\/s10147-011-0368-2","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,12]]}}}